These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29096935)

  • 1. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
    Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
    J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
    Goel R; Danda D; Kumar S; Joseph G
    Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
    Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
    Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome.
    Misra DP; Aggarwal A; Lawrence A; Agarwal V; Misra R
    Rheumatol Int; 2015 Oct; 35(10):1701-6. PubMed ID: 25903354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor obstetric outcomes in Indian women with Takayasu arteritis.
    Gupta L; Misra DP; Ahmed S; Jain A; Zanwar A; Lawrence A; Agarwal V; Aggarwal A; Misra R
    Adv Rheumatol; 2020 Mar; 60(1):17. PubMed ID: 32164787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Diagnosis and Management of Takayasu Arteritis.
    As C; Danda D
    Int Heart J; 2023; 64(4):519-534. PubMed ID: 37518335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study.
    Goel R; Nair A; Kabeerdoss J; Mohan H; Jeyaseelan V; Joseph G; Danda D
    Rheumatol Int; 2018 Apr; 38(4):623-630. PubMed ID: 29196802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).
    Misra R; Danda D; Rajappa SM; Ghosh A; Gupta R; Mahendranath KM; Jeyaseelan L; Lawrence A; Bacon PA;
    Rheumatology (Oxford); 2013 Oct; 52(10):1795-801. PubMed ID: 23594468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review.
    Abisror N; Mekinian A; Lavigne C; Vandenhende MA; Soussan M; Fain O;
    Autoimmun Rev; 2013 Oct; 12(12):1143-9. PubMed ID: 23820042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom.
    Eleftheriou D; Varnier G; Dolezalova P; McMahon AM; Al-Obaidi M; Brogan PA
    Arthritis Res Ther; 2015 Feb; 17(1):36. PubMed ID: 25879697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort.
    Cui X; Dai X; Ma L; Yang C; Tan W; Zhang L; Zhang Z; Feng X; Wu R; Zou Y; Zhou Z; Lu Y; Wang Y; Wu M; Li S; Wang L; Lin H; Dong Z; Fu W; Sun X; Wang C; Ding J; Lv P; Lin J; Jiang L;
    Semin Arthritis Rheum; 2020 Feb; 50(1):59-65. PubMed ID: 31350057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide in Takayasu arteritis - A long term observational study.
    de Souza AW; de Almeida Agustinelli R; de Cinque Almeida H; Oliveira PB; Pinheiro FA; Oliveira AC; Sato EI
    Rev Bras Reumatol Engl Ed; 2016; 56(4):371-5. PubMed ID: 27476631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
    Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in Takayasu's arteritis.
    Goel R; Danda D; Mathew J; Edwin N
    Clin Rheumatol; 2010 Mar; 29(3):329-32. PubMed ID: 20054700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient Use of Corticosteroids without Immunosuppressants Results in Higher Relapse Rates in Takayasu Arteritis.
    Mutoh T; Shirai T; Fujii H; Ishii T; Harigae H
    J Rheumatol; 2020 Feb; 47(2):255-263. PubMed ID: 31092708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
    Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
    Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
    Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.